Tag: Cancer: Misc.
Genetic Tests May Differ in Their Interpretation of Certain Variants
11 percent of interpretations were different for TP53 gene; difference can impact management
June 2020 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for June 2020. This roundup includes...
American Association for Cancer Research, June 22-24
The American Association for Cancer Research Annual Meeting 2020 The American Association for Cancer Research held a second virtual meeting as part of...
Quality of Life Worse for Cancer Patients During COVID-19
Quality of life significantly lower than reference group; symptom scales worse, including insomnia
More Sedentary Time Tied to Higher Risk for Cancer Mortality
Replacing sedentary time with 30 minutes of light or moderate physical activity cuts risk
African-American Participation Inadequate in Cancer Drug Trials
Consistent underrepresentation seen in clinical trials evaluating medications across major cancer types
Financial Hardship Linked to More ED Visits in Cancer Survivors
Medical financial hardship linked to lower uptake of influenza vaccine, lower breast cancer screening
Cardioprotective Therapy Use Lower With Cancer History
Utilization rate of antiplatelet therapies and statins significantly lower for patients with cancer history
Considerable National Costs Attributed to Cancer Medical Care
Overall annualized average costs highest for end-of-life cancer phase followed by initial, continuing phases
Racial/Ethnic Disparities Seen in Economic Burden Due to Cancer Deaths
Non-Hispanic blacks have higher age-standardized PYLL, lost earning rates than whites for 13 of 19 sites
